Accelerated Pubertal Tempo in a 46,XY Aromatase-Deficient Patient

Background: Aromatase deficiency is a rare autosomal recessive disorder. 46,XY-affected patients often remain undiagnosed until late puberty. Only 2 pediatric cases have been reported. Data on pubertal development in affected males are scarce. Aim: To report the clinical phenotype and hormonal studies of an aromatase-deficient boy during the prepubertal and early pubertal period. Results: The patient was the older brother of a 46,XX girl with aromatase deficiency. Molecular analysis revealed a previously reported homozygous mutation (Arg192Cys) in the CYP19A1 gene. Pubertal onset was at 9.8 years. At 11.3 years of age, signs of rapidly progressive puberty were seen. Laboratory tests revealed normal pubertal basal and GnRH-stimulated gonadotropin levels, normal Sertoli cell markers, and increased testosterone. The prepubertal lumbar spine bone mineral density (BMD) was normal but pubertal bone mineral accrual was incomplete, leading to osteopenia. Conclusion: Estrogen restraint on gonadotropin secretion has been demonstrated in animal and human models. Interestingly, our patient presented with accelerated puberty and apparently normal pituitary gonadal function. These findings suggest that aromatase activity may be required to define pubertal progression in boys. Estrogen deficiency due to aromatase deficiency is responsible for insufficient bone mineral accrual during puberty.

[1]  N. Bishop,et al.  Amalgamated Reference Data for Size‐Adjusted Bone Densitometry Measurements in 3598 Children and Young Adults—the ALPHABET Study , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  S. Hammes,et al.  Aromatase deficiency in a male patient - Case report and review of the literature. , 2016, Bone.

[3]  W. Wallace,et al.  A Normative Model of Serum Inhibin B in Young Males , 2016, PloS one.

[4]  B. Walker,et al.  Aromatase Inhibition Reduces Insulin Sensitivity in Healthy Men , 2016, The Journal of clinical endocrinology and metabolism.

[5]  A. Belgorosky,et al.  Five new cases of 46,XX aromatase deficiency: clinical follow-up from birth to puberty, a novel mutation, and a founder effect. , 2015, Journal of Clinical Endocrinology and Metabolism.

[6]  Amit V. Pandey,et al.  Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies , 2014, Molecular and Cellular Endocrinology.

[7]  S. Bulun Aromatase and estrogen receptor α deficiency. , 2014, Fertility and sterility.

[8]  R. Rey,et al.  Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21. , 2011, International journal of andrology.

[9]  T. Hangartner,et al.  Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. , 2010, The Journal of clinical endocrinology and metabolism.

[10]  A. Belgorosky,et al.  Metformin, Estrogen Replacement Therapy and Gonadotropin Inhibition Fail to Improve Insulin Sensitivity in a Girl with Aromatase Deficiency , 2009, Hormone Research in Paediatrics.

[11]  A. Belgorosky,et al.  Genetic and Clinical Spectrum of Aromatase Deficiency in Infancy, Childhood and Adolescence , 2009, Hormone Research in Paediatrics.

[12]  V. Rochira,et al.  Aromatase deficiency in men: a clinical perspective , 2009, Nature Reviews Endocrinology.

[13]  E. Ghigo,et al.  A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. , 2008, Bone.

[14]  N. Mauras,et al.  Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated With Growth Hormone : A Randomized, Placebo-Controlled, Multicenter Trial for One to Three Years , 2008 .

[15]  W. Crowley,et al.  The relative role of gonadal sex steroids and gonadotropin-releasing hormone pulse frequency in the regulation of follicle-stimulating hormone secretion in men. , 2008, The Journal of clinical endocrinology and metabolism.

[16]  L. Maffei,et al.  Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. , 2006, European journal of endocrinology.

[17]  L. Dunkel,et al.  Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. , 2005, The Journal of clinical endocrinology and metabolism.

[18]  K. Mann,et al.  Effects of estrogen replacement therapy on bone and glucose metabolism in a male with congenital aromatase deficiency. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[19]  S. Boonen,et al.  Estrogens are essential for male pubertal periosteal bone expansion. , 2004, The Journal of clinical endocrinology and metabolism.

[20]  Laura Maffei,et al.  Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment. , 2004, The Journal of clinical endocrinology and metabolism.

[21]  A. Belgorosky,et al.  Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene. , 2003, The Journal of clinical endocrinology and metabolism.

[22]  T. Saibara,et al.  Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. , 2003, The Journal of endocrinology.

[23]  A. Belgorosky,et al.  Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  L. Dunkel,et al.  The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor. , 2002, European journal of endocrinology.

[25]  W. Crowley,et al.  Importance of inhibin B in the regulation of FSH secretion in the human male. , 2001, The Journal of clinical endocrinology and metabolism.

[26]  L. Dunkel,et al.  A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial , 2001, The Lancet.

[27]  W. Crowley,et al.  Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. , 2000, The Journal of clinical endocrinology and metabolism.

[28]  N. Harada,et al.  Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. , 1999, The Journal of clinical endocrinology and metabolism.

[29]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[30]  G. Puavilai,et al.  Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. , 1999, Diabetes research and clinical practice.

[31]  J. Bilezikian,et al.  Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. , 1998, The New England journal of medicine.

[32]  G. Kletter,et al.  Acute effects of estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys. , 1997, The Journal of clinical endocrinology and metabolism.

[33]  K. Korach,et al.  Effect of testosterone and estradiol in a man with aromatase deficiency. , 1997, The New England journal of medicine.

[34]  E. Simpson,et al.  Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. , 1995, The Journal of clinical endocrinology and metabolism.

[35]  P. A. Lee,et al.  Normal ranges for immunochemiluminometric gonadotropin assays. , 1995, The Journal of pediatrics.

[36]  Y. Ito,et al.  Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. , 1994, Endocrine reviews.

[37]  W J Bremner,et al.  The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. , 1994, Journal of andrology.

[38]  C. Mendelson,et al.  Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. , 1991, Molecular endocrinology.

[39]  W. Crowley,et al.  Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. , 1991, The Journal of clinical endocrinology and metabolism.

[40]  N. Harada,et al.  Structural characterization of the human estrogen synthetase (aromatase) gene. , 1990, Biochemical and biophysical research communications.

[41]  J. Mathis,et al.  Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. , 1989, The Journal of biological chemistry.